HLA Polymorphism and Blood Biomarkers in Parkinson’s Disease
Author Information
Author(s): Minibajeva Olga, Karelis Guntis, Zolovs Maksims, Ķēniņa Viktorija
Primary Institution: Rīga Stradiņš University
Hypothesis
This pilot study aimed to identify potential risk and protective human leukocyte antigen (HLA) alleles in Parkinson's disease and evaluate potential blood biomarkers.
Conclusion
The study found that certain HLA alleles are associated with Parkinson's disease and identified S100 calcium-binding protein A9 and kynurenic acid as potential blood biomarkers.
Supporting Evidence
- The HLA-DRB1*04 allele was significantly more frequent in PD patients.
- S100A9 levels were significantly higher in PD patients compared to controls.
- Kynurenic acid levels were significantly lower in PD patients.
- The study highlights the need for more genetic studies in Baltic populations.
Takeaway
Researchers looked at blood samples from people with Parkinson's disease to find out if certain genes and proteins could help understand the disease better.
Methodology
The study analyzed HLA polymorphism and blood levels of specific biomarkers in 43 PD patients and 79 controls.
Potential Biases
Potential bias due to the small number of participants and reliance on self-reported data for age at onset.
Limitations
The small sample size limited statistical analysis and some testing methods lacked precision.
Participant Demographics
43 PD patients, 53.5% female, mean age 65 years.
Statistical Information
P-Value
p<0.001 for HLA-DRB1*04 allele frequency.
Confidence Interval
Wide confidence interval for HLA-DRB1*04 may affect reliability.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website